Michael John Allingham MD PhD
Retinal Disease
Assistant Professor of Ophthalmology Duke Center for Macular Diseases Duke Eye Center
Join to View Full Profile
2301 Erwin RdDurham, NC 27705
Phone+1 919-684-8111
Dr. Allingham is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Summary
- Dr. Michael Allingham is an ophthalmologist based in Durham, NC, with a subspecialty in retinal diseases and particular expertise in medical treatment of macular and retinal vascular diseases. He completed his internship and residency at Duke University Hospital after earning his MD/PhD from the University of North Carolina at Chapel Hill in 2009. Dr. Allingham has contributed to numerous peer-reviewed publications focusing on basic and clinical science of macular diseases including age-related macular degeneration, diabetic macular edema and retinal vein occlusion.
Education & Training
Duke University HospitalResidency, Ophthalmology, 2010 - 2013- Duke University HospitalInternship, Internal Medicine, 2009 - 2010
University of North Carolina at Chapel Hill School of MedicineClass of 2009
Certifications & Licensure
NC State Medical License 2013 - 2025
VA State Medical License 2013 - 2020
American Board of Ophthalmology Ophthalmology
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2013
Clinical Trials
Publications & Presentations
PubMed
- Association of Hyperautofluorescence Signals with Geographic Atrophy Progression in the METformin for the MINimization of Geographic Atrophy Progression Trial.Abu Tahir Taha, Liangbo Linus Shen, Antonio Diaz, Noor Chahal, Jasmeet Saroya
Ophthalmology Science. 2024-09-12 - 5 citationsA Deep-Learning Algorithm to Predict Short-Term Progression to Geographic Atrophy on Spectral-Domain Optical Coherence Tomography.Eliot R Dow, Hyeon Ki Jeong, Ella Arnon Katz, Cynthia A Toth, Dong Wang
JAMA Ophthalmology. 2023-11-01 - 1 citationsFluorescein CorneoGraphy (FCG): Use of a repurposed fluorescein imaging technique to objectively standardize corneal staining.Matias Soifer, Nadim S Azar, Ricardo Blanco, Hazem M Mousa, Seyyedehfatemeh Ghalibafan
The Ocular Surface. 2023-01-01
Press Mentions
Q&A: Our Role in Reducing Diabetic Retinopathy MortalityJanuary 27th, 2025- Ocuphire Pharma : Announces Financial Results for the Second Quarter 2022 and Provides Corporate Update - Form 8-KAugust 15th, 2022
- Ocuphire Announces Financial Results for the Fourth Quarter and Year Ended December 31, 2021 and Provides Corporate UpdateMarch 24th, 2022
- Join now to see all
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
